E
eVisit
Simplifying healthcare delivery so hospitals can provide care when and where it’s needed
About eVisit
eVisit is a digital health startup that provides a platform for large health systems to build their own virtual hospitals. The company's solution is designed to transform traditional care delivery pathways by integrating virtual and hybrid care workflows across both acute and ambulatory settings. This means that eVisit's platform can be used to operate various healthcare programs such as Virtual Nursing, ED Triage, primary, urgent, and specialty care.
The company's platform is designed to be accessible and easy to use, addressing a common concern among healthcare executives that they lose patients to competitors that offer easier access to care. eVisit's platform is designed to improve patient experiences, which is why their customers experience 42% higher adoption rates.
eVisit's platform is also highly configurable and flexible, with over 150 points of configuration. This makes it capable of handling almost any workflow, which is why their customers see a 5.8X return on investment.
eVisit's business model is based on providing a platform for healthcare providers to deliver virtual and hybrid care to their patients using their own network of clinicians. This is a key differentiator for eVisit, as most telehealth vendors are also healthcare providers that compete for the same patients. Since its inception in 2015, eVisit's platform has been used by physicians in over 50 specialties.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Mesa, United States
- Employees
- 86
- Open positions
- 4
- Dealroom signal
- 65.0/100
- Industry
- Health, Enterprise Software
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Telemedicine, Hospital Logistics, Tech for Hospitals and Clinics, Tech for Patients, Hard Tech
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 1 company, latest Apr 2023
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Sep 2021 | $45M | $180M | Steven Barlow · Texas Health Resources · MedStar Health · Goldman Sachs Asset Management | ↗ |
| SERIES AOther financing | Oct 2020 | $14M | $56M | University Growth Fund · Kickstart Fund · Jeremy Andrus · TVC Capital | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for eVisit is 140K monthly website visits, up 40% over the last three months. eVisit's team declined 13.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed8 investors entered at this stage
Grayhawk Capital
MRTNZ Ventures
Kickstart Fund- SCService Provider Capital
Alan Ram's Proactive Training Solutions
Sam Blackman
Alan Ram- CRChris Reap
Series A9 investors entered at this stage
TVC Capital
University Growth Fund
Jeremy Andrus
Steven Barlow
Texas Health Resources
MedStar Health
Goldman Sachs Asset Management
UPMC Enterprises- TBTom Burton
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about eVisit on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See eVisit’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








